Cannabinoid Combination Targets <i>NOTCH1</i> -Mutated T-ALL Through the Integrated Stress Response Pathway

Elazar Besser(Technion – Israel Institute of Technology), David Meiri(Technion – Israel Institute of Technology)

bioRxiv (Cold Spring Harbor Laboratory)

August 21, 2023

10.1101/2023.08.20.554002

Cited by 0

Related Papers

The heterogeneity and complexity of <i>Cannabis</i> extracts as antitumor agents

|Oncotarget|2019|98

Mechanistic insight into GPCR-mediated activation of the microtubule-associated RhoA exchange factor GEF-H1

|Nature Communications|2014|65

Cannabis for Medical Use: Versatile Plant Rather Than a Single Drug

|Frontiers in Pharmacology|2022|49

Decreased melanoma CSF-1 secretion by Cannabigerol treatment reprograms regulatory myeloid cells and reduces tumor progression

|OncoImmunology|2023|19

Cannabinoid combination targets NOTCH1-mutated T-cell acute lymphoblastic leukemia through the integrated stress response pathway

|eLife|2023|7